Cargando…
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259662/ https://www.ncbi.nlm.nih.gov/pubmed/37101393 http://dx.doi.org/10.1002/cac2.12425 |
| _version_ | 1785057706911989760 |
|---|---|
| author | Karimi, Leena Alves, Carla L. Terp, Mikkel G. Tuttolomondo, Martina Portman, Neil Ehmsen, Sidse Johansen, Lene E. Bak, Martin Lim, Elgene Ditzel, Henrik J. |
| author_facet | Karimi, Leena Alves, Carla L. Terp, Mikkel G. Tuttolomondo, Martina Portman, Neil Ehmsen, Sidse Johansen, Lene E. Bak, Martin Lim, Elgene Ditzel, Henrik J. |
| author_sort | Karimi, Leena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10259662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102596622023-06-13 Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor Karimi, Leena Alves, Carla L. Terp, Mikkel G. Tuttolomondo, Martina Portman, Neil Ehmsen, Sidse Johansen, Lene E. Bak, Martin Lim, Elgene Ditzel, Henrik J. Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2023-04-26 /pmc/articles/PMC10259662/ /pubmed/37101393 http://dx.doi.org/10.1002/cac2.12425 Text en © 2023 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Karimi, Leena Alves, Carla L. Terp, Mikkel G. Tuttolomondo, Martina Portman, Neil Ehmsen, Sidse Johansen, Lene E. Bak, Martin Lim, Elgene Ditzel, Henrik J. Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title | Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title_full | Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title_fullStr | Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title_full_unstemmed | Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title_short | Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor |
| title_sort | triple combination targeting pi3k, er, and cdk4/6 inhibits growth of er‐positive breast cancer resistant to fulvestrant and cdk4/6 or pi3k inhibitor |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259662/ https://www.ncbi.nlm.nih.gov/pubmed/37101393 http://dx.doi.org/10.1002/cac2.12425 |
| work_keys_str_mv | AT karimileena triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT alvescarlal triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT terpmikkelg triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT tuttolomondomartina triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT portmanneil triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT ehmsensidse triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT johansenlenee triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT bakmartin triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT limelgene triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor AT ditzelhenrikj triplecombinationtargetingpi3kerandcdk46inhibitsgrowthoferpositivebreastcancerresistanttofulvestrantandcdk46orpi3kinhibitor |